Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
US Bill Aims to Ban Corporate Ownership of Medical Practices
Management & Regulatory US Bill Aims to Ban Corporate Ownership of Medical Practices

Prohibiting management services organizations from owning equity or financing physician ownership could force a massive restructuring of the current healthcare investment market. Launched in late 2026, the Stop Corporate Takeovers of Physicians Act serves as a definitive federal intervention into

The Gut-Brain Axis and Global Equity in MS Precision Medicine
Tech & Innovation The Gut-Brain Axis and Global Equity in MS Precision Medicine

The significant gender imbalance in multiple sclerosis suggests a sex-microbiota-immune axis that requires specialized analysis to develop effective personalized treatments. The scientific understanding of multiple sclerosis (MS) is currently undergoing a significant paradigm shift. Once viewed

Can AI Improve the Staging of COVID-19 Lung Infections?
Tech & Innovation Can AI Improve the Staging of COVID-19 Lung Infections?

The volumetric extent of ground-glass opacities and consolidations serves as a critical marker for determining the stage of a viral lung infection. In the high-pressure environment of intensive care, doctors must constantly decipher whether a patient is on the path to recovery or teetering on the

iRhythm Growth Tested by Significant 2026 Cybersecurity Breach
Management & Regulatory iRhythm Growth Tested by Significant 2026 Cybersecurity Breach

A gross margin expansion to 72.8% in the second quarter of 2026 demonstrated iRhythm's operational scaling just as a significant cybersecurity crisis unfolded. The intersection of these two events creates a paradox for the digital healthcare giant, which has seen its Zio platform achieve

ZETA and BeneMeat Partner to Scale Up Cultivated Meat
Management & Regulatory ZETA and BeneMeat Partner to Scale Up Cultivated Meat

BeneMeat’s partnership with the Italian brand FORZA10 serves as a practical case study for the commercial application of cultivated cells in the animal feed sector. This collaboration marks a significant milestone in the broader trajectory of cellular agriculture, moving beyond speculative research

Can YOLOv11 Revolutionize Orthodontic Jaw Expansion?
Tech & Innovation Can YOLOv11 Revolutionize Orthodontic Jaw Expansion?

The biological window for non-surgical jaw expansion is narrow, making the accurate timing of orthodontic intervention a critical factor for long-term patient outcomes. Maxillary expansion is a staple of pediatric dentistry, but the threshold between a simple mechanical procedure and a complex

CAR-M Therapy Offers a New Frontier for Solid Tumor Treatment
Research & Development CAR-M Therapy Offers a New Frontier for Solid Tumor Treatment

Combining CAR-M with checkpoint inhibitors such as PD-1 blockers creates a multi-pronged therapeutic strategy that addresses the biological complexity of solid tumors more effectively than monotherapy. The landscape of precision medicine is shifting as chimeric antigen receptor technologies evolve

Mosquito Genomic Study Boosts Malaria Control in Burkina Faso
Tech & Innovation Mosquito Genomic Study Boosts Malaria Control in Burkina Faso

Whole-genome sequencing of mosquito specimens from across Burkina Faso has provided a high-resolution map of the single nucleotide polymorphisms that drive malaria transmission. This extensive genomic survey, orchestrated by a multi-institutional coalition including the Burkinabé Ministry of Health

Michigan Doctor Convicted in $100 Million ADHD Pill Scheme
Management & Regulatory Michigan Doctor Convicted in $100 Million ADHD Pill Scheme

The case of Dr. Jonathan Decker serves as a stark warning to medical professionals that a license to practice is a public trust that cannot be legally traded for profit. As the digital healthcare landscape continues to evolve in 2026, the federal conviction of this 46-year-old physician highlights

How Will the 2026 DHHS Agenda Reshape Clinical Research?
Research & Development How Will the 2026 DHHS Agenda Reshape Clinical Research?

Proposed revisions to human subject protections aim to ease the regulatory load on learning health systems while introducing more practical exemptions for low-risk research categories. The Department of Health and Human Services (DHHS) recently unveiled a comprehensive Unified Agenda that signals a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later